Meanwhile, the early HCC (BCLC 0‐A) patients with PIVKA‐II (+) and AFP (+) were associated with increased risks of postoperative recurrences, especially those with positive MVIs. The gene discussed is AFP; the disease is hepatocellular carcinoma.